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ABSTRACT One of the major surprises of the molecular
analysis of major histocompatibility complex (MHC) genes is
the large number of class I (K/D)-related sequences in the
genome. Both restriction fragment length polymorphisms and
cosmid cloning experiments showed them all to be closely linked
to the MHC. Until now little information was available con-
cerning either their expression or recognition by the immune
system. Here we report that these non-K/D genes can provoke
antibody responses and be recognized by cytolytic T cells.
Immunization of C3H mice with L cells transfected with class
I genomic clones resulted in antisera that reacted preferentially
with cells from strain B10.P (the gene donor). Thus, these genes
can be expressed by L cells. These products were recognized by
cytolytic T cells produced by mixed lymphocyte culture with
B10.P stimulators. One gene, represented in clone X3a, was
chosen for further analysis. A restriction fragment length
polymorphism, detected between B10.P (KPDP) and
B10.F(14R) (KbDp) and between B10 (KbDb) and B10.F(13R)
(KPDb), has enabled us to map the X3a sequence to theD or Tla
region. Restriction endonuclease mapping of the A3a clone
shows that the gene is intact and that, although many restric-
tion sites are conserved, the gene in A3a differs from other class
I genes. When the A3a clone was transfected into mouse L cells,
a new product was expressed. Cells expressing this product
(designated L3a cells) were killed by primary D-end-reactive,
allospecific cytolytic T lymphocytes. The L3a cells were unreac-
tive with monoclonal antibodies specific for the KP,DP,Qa-2,
Tla.3, and Tla.5 molecules.
The classical class I histocompatibility molecules of the
mouse, H-2K, H-2D, and H-2L, are 45-kDa membrane-
bound glycoproteins. These molecules are found on the cell
membrane in association with,82-microglobulin. The K, D,
and L class I molecules function in the immune recognition
of viral cell-surface antigens as well as allogeneic cells by
cytolytic T lymphocytes (CTLs) (1, 2). This obligatory self-
recognition is termed H-2 restriction. Localized telomeric to
the D gene are the Tla and Qa regions, which contain other
members of the class I gene family. These genes code for the
Tla, Qa-1, and Qa-2 antigens which are expressed primarily
on hematopoietic cells (3). Qa antigens are found on
thymocytes, peripheral T and B cells, and lymphoblasts,
whereas Tla antigens are found on intrathymic T cells and
some T-cell leukemias. Unlike H-2 K, D, and L antigens, Qa
and Tla do not elicit a primary mixed-lymphocyte response
(MLR) or function as target cells of primary CTLs (4, 5). Qa
and Tla antigens can, however, function as unrestricted CTL
targets and can be detected by in vivo "priming" followed by
in vitro "boosting" (6). By virtue of their limited expression
compared to K or D, Qa and Tla antigens are thus tissue-
specific class I antigens (3).
Molecular analysis has shown that K, D, L, and Qa/Tla
represent only a fraction of the class I gene family. Southern
blot analysis and cosmid cloning have shown that the mouse
class I gene family has 25-35 members, all encoded on
chromosome 17 (7). It is not known which, if any, of the
non-KIDIL/Qa/Tla class I sequences are transcribed or
have any biological function.
The possibility that the Tla and Qa genes are also ex-
pressed in nonhematopoietic tissues has been suggested
(8-10). The DNA sequence of the cDNA clone pH16 suggests
an unusual peptide, which lacks a transmembrane region and
would probably be a secreted product. Mellor et al. (11)
determined the nucleotide sequence of a class I genomic
clone (Q10), located in the Qa-2,3 region, to be identical to
the pH16 cDNA sequence.
The isolation of genomic DNA clones encoding class I
molecules and their subsequent transfer and functional
expression in mouse L cells has allowed us and others to
characterize cell surface major histocompatibility complex
(MHC) molecules and to perform immunologic experiments
on the role of class I gene products (12-19). We have begun
to use DNA-mediated gene transfer to characterize a series
of genomic clones isolated from a mouse strain B1O.P sperm
library. Here we describe evidence for the expression of
several of these genes in L cells, and a more detailed analysis
of one of the clones (A3a). Immunization of C3H/HeJ (H-2k)
mice with transfected L cells resulted in the production of
antibodies specific for B10.P (H-2P) spleen cells. Similarly
B10 anti-BlO.P killer cells recognize L cells transfected with
B10.P class I genes but not L cells transfected with the
herpesvirus thymidine kinase (TK) gene. The X3a product
therefore functions, as do the K and D class I molecules, as
a target for primary allospecific CTLs. The functional sig-
nificance of the X3a gene and related class I genes is
discussed.
MATERIALS AND METHODS
Mice. All mice (except C3H/HeJ) were bred and housed in
our animal colony at the University of North Carolina. The
C3H/Fre subline was descended from breeders provided by
F. Bang (Johns Hopkins, Baltimore, MD). C3H/HeJ mice
were purchased from The Jackson Laboratory (Bar Harbor,
ME).
Abbreviations: CTL, cytotoxic T lymphocyte; MHC, major histo-
compatibility complex; RFLP, restriction fragment length polymor-
phism; bp, base pair(s); kb, kilobase(s).
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Cell Lines. The C3H (H-2k) mouse fibroblast cell line LTK-
was derived from a thymidine kinase-deficient mutant of L929
cells. The Rat-2 cell line is a TK- fibroblast line derived from
Fischer rats. L3a, L5b, L12a, L15a, and L17a are cloned cell
lines derived by the cotransfection of LTK- cells with the
herpes TK gene and class I genomic clone O3a, X12a, X15a,
or X17a. The genomic DNA clones were selected from a
B1O.P sperm DNA library as described (12). Transfection of
LTK- cells was as described (12). Cells were maintained in
RPMI 1640 medium supplemented with 5% fetal bovine
serum, 10 mM Hepes, penicillin and streptomycin, and
hypoxanthine/aminopterin/thymidine (20).
Monoclonal Antibodies and Alloantisera. All H-2P-specific
monoclonal antibodies used have been described (21). All
monoclonal antibodies were elicited by intraperitoneal injec-
tion of lymphoid cells. Alloantiserum (C3H/HeJ anti-L-cell
antibodies) was produced by multiple intraperitoneal immu-
nizations with 5 x 107 irradiated (3000 rads) transfected L
cells. Fischer rats were immunized by intraperitoneal injec-
tion of 2.5 x 107 transfected R3a.6 cells. Qa-specific al-
loantisera were kindly provided by L. Flaherty (New York
State Department of Health, Albany), and Tla-specific mono-
clonal antibodies by F. W. Shen (22, 23).
Restriction Enzyme Mapping of the A3a Gene. The cloned
X3a DNA was characterized by digestion with a variety of
restriction endonucleases [New England Biolabs or Inter-
national Biotechnologies (New Haven, CT)]. X3a DNA was
digested with appropriate enzymes for 3 hr at 37°C and then
electrophoresed for 500 volt-hr in 0.8% agarose gel and
blotted to nitrocellulose according to the method of Southern
(24). Blots were hybridized with the class I cDNA probes
pH-2111 (5') and pH-211a (3'), as described (12, 25).
Mapping of Restriction Fragment Length Polymorphisms.
RFLPs were studied by mapping genomic DNAs prepared
from livers of B1O.P (KPDP), B1O.F(13R) (KPDb), B1O.F(14R)
(KbDP), and B10 (KbDb) mouse strains. The genomic DNAs
along with X3a DNA were digested with Sac I for 3 hr at 37°C
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and the blots were hybridized with the nick-translated cDNA
clone pH-2IIa.
Analysis of CTL Target Function. Alloreactive CTLs were
produced according to published procedures (26, 27). Eryth-
rocyte-depleted spleen cells were mixed at equal concentra-
tions (2.5 x 107 each) of responders and irradiated (2000 rad)
stimulators, and cultured for 5 days at 37°C in a humidified
7.5% CO2 atmosphere in 20 ml of Click's medium with 5%
fetal bovine serum. CTL activity was measured in a standard
4-hr 51Cr-release assay (27). Percent specific lysis was cal-
culated as [(cpm experimental - cpm spontaneous)/(cpm
maximal - cpm spontaneous)] x 100.
Complement-Mediated Microcytotoxicity Analysis. The re-
activity of alloantiserum from C3H/HeJ anti-L3a immune
mice was studied with a panel of inbred and H-2 recombinant
inbred mouse strains in a two-step complement-dependent
microcytotoxicity assay (28). Selected rabbit serum was used
as a source of complement. Splenocytes were isolated after
sedimentation with Lympholyte M (Cedarlane Laboratories,
Hornby, ON) and the test was performed in duplicate in
Terasaki plates. Complement-only (control) cytotoxicity was
always <10%.
RESULTS
Transfected Cells Induce H-2P Reactive Antibodies. Several
class I genomic clones have been isolated from a B10.P
library that were found not to encode classical K or D
antigens. To determine whether these cloned class I genes
can be expressed, we used L cells transfected with class I
genes to provoke an antibody response in C3H mice. It has
been shown that such an approach is feasible and that
immunization ofC3H mice with transfected L cells evokes an
antibody response against the transfected-gene product (29).
When C3H mice, which are syngeneic with the original L929
cell line, were immunized with H-2P-transfected L cells,
antibodies with B10.P derived cells were evoked. Fig. 1
shows the results of a cytotoxicity test with C3H anti-L3a,
C3H anti-LSb, C3H anti-L12a, C3H anti-LiSa, and C3H
Antiserum dilution-'
FIG. 1. Direct cytotoxicity test of antisera raised against L-cell transformants. Target cells were from B1O.P (o) or C3H (o) mice. (A) C3H
anti-L3a. (B) C3H anti-L5b. (C) C3H anti-L12a. (D) C3H anti-L15a. (E) C3H anti-L17a. Complement-alone controls all gave 610% killing.
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anti-L17a antisera and mesenteric lymph-node cell targets.
All sera showed preferential reactivity with B1O.P cells over
C3H cells. C3H anti-L12a was included as a positive control,
since X12a has been shown to carry the DP gene (12). This
serum shows specific reactivity for B1O.P cells. Three of the
remaining four sera showed variable but clear-cut, specific
reactivity. The fourth, C3H anti-L5b showed only slight
specific reactivity with B1O.P cells. These results show that
the transfected cells express a product that can provoke
antibodies reactive with cells from the gene donor. Further
analysis of these sera revealed that they are complex and
contain antibodies broadly crossreactive among the antigens
encoded by the H-2 class I gene family (unpublished data).
For example, the B10 anti-L3a serum reacts with both B10
and B1O.P lymph node cells. Surprisingly this serum failed to
react with BlO.F(14R) (KbDP) cells but did react with
BlO.F(13R) (KPDb) cells. This pattern suggests crossreac-
tivity of the X3a product with KP and/or Db/Tlab/Qab but not
the QaP products. Adsorption shows that B1O.P cells com-
pletely adsorb the reactivity for BlO cells. Either the only
antibody present is the X3a product KP-crossreactive anti-
body or the X3a product cannot be detected by direct test but
the H-2b-reactive antigen can.
The high and variable activity against C3H targets by the
antisera may be due to variable crossreactivity of the anti-
bodies with the transfected product and Kk/Dk expressed on
the C3H cells. Alternatively, an autoantibody might be
induced by immunization with antigen similar to a self-
antigen. This is likely since the TL/Qa-region-encoded class
I molecules are much less polymorphic than K or D.
A similar antiserum was prepared by immunizing Fischer
rats with Rat-2 cells transfected with the X3a gene. This
serum showed reactivity with L3a cells and Rat-2 cells
transfected with the X3a gene but not with untransfected
LTK- or Rat-2 cells (data not shown).
As has been seen often, immunization with tumor cells
results in the production of high titers of antibodies to the
70-kDa glycoprotein gp7O and other associated products
(e.g., anti-fetal calf serum). Because of the high concentra-
tions of these antibodies, attempts to produce gene-specific
antibodies by adsorption using transfected L cells were
unsuccessful.
To eliminate the possibility that we had cloned Qa-2 or Tla
genes from H-2P mice, we tested the transfected lines with
anti-Tla and anti-Qa-2 antibodies. Qa-1 is not expressed in
H-2P strains. In direct binding tests using transfected L-cell
targets, no reactivity was seen with anti-Tla.3 or -Tla.5 or
anti-Qa-2 antibodies (data not shown).
Transfected Cells are Recognized by Allospecific CTLs. We
wished to determine whether the products of the class I genes
transfected into L cells could be recognized by allospecific
CTLs. We prepared B10 anti-B1O.P; B10 anti-BlO.K; and
B1O.K anti-BlO.P effector cells. These cells were tested on
uncloned L3a, L12a, and L15a and on LTK+ cells. As seen
in Table 1, L12a (L cells transfected with the DP gene) were
efficiently killed by B10 anti-B1O.P effectors. L3a and L15a
were also killed, but LTK+ cells were not. All cells tested
were killed by B10 anti-B1O.K killer cells, indicating that the
cells expressed endogenous H-2k antigen and could be lysed
by CTLs. Third-party specific killers (B1O.K anti-B10) were
Table 1. Killing of transfected cells by allospecific CTLs
% specific 5"Cr release of targets
Effector cells L3a L12a LISa LTK+
B10 anti-BlO.P 35 28 19 9
B10 anti-BlO.K 42 47 46 50
B1O.K anti-B10 8 9 5 10
All effectors were tested at 50:1 effector/target ratio.
ineffective. Thus both L3a and LiSa could be recognized by
BlO.P-specific killer cells, demonstrating that the product
was recognized by T cells and that the product was expressed
on the cell surface.
We chose to focus on the X3a gene because (i) cells
transfected with the O3a gene provoked an antibody re-
sponse, (ii) L cells transfected with the gene were recognized
by CTLs, and (iii) a convenient RLFP was available for
mapping (see below).
L3a Cells Act as CTL Targets for D-End-Specific Killer
Cells. We wished to know whether the O3a product expressed
in L3a cells could be recognized by subregion-allospecific
CTLs. CTLs were produced in vitro by use of B10 responders
and BlO.F(14R) stimulators. These effectors are D-end-
specific because both BlO.F(14R) and B10 mice K and I
regions are KbYb. These effectors then were assayed for
cytolytic activity in a standard 4-hr chromium-release assay
using 5tCr-labeled Con A-stimulated lymphoblasts, LTK+
cells, L12a cells (L cells transfected with the DP gene), or the
L3a cells as target cells (Fig. 2). BlO.F(14R) lymphoblasts,
L12a cells, and L3a cells all were efficiently killed by the B10
effector cells. B10, B10.F(13R) (KPDb), and LTK+ cells were
not recognized. This result is consistent with mapping of the
specificity to the D end ofH-2P. Similar results were obtained
with B1O.F(13R) anti-B1O.F(14R) effector cells (data not
shown).
Thus, L3a cells express an H-2P-derived D-end gene
product that can be recognized by CTLs. Since B10 (H-2b)
and L3a cells (H-2k + A3a) share no MHC-derived compo-
nents, the recognition of the L3a cells must not be H-2-
restricted. Thus, the A3a product shares the property of other
class I genes as an unrestricted CTL target. It cannot,
however, be assumed that the stimulating antigen on B1O.P
and BlO.F(14R) spleen cells is the same molecule as that
expressed on L3a cells. Nevertheless, our results show that
the A3a gene product is expressed on the cell surface and can
be recognized by BlO.P- and B1O.F(14R)-specific CTL.
Restriction Map of X3a. The restriction endonuclease
mapping of genomic DNA clones containing class I genes
isolated from a BiO.P sperm DNA library has been described
for the H-2DP gene (12). A restriction map ofthe cloned insert
in A3a (Fig. 3) shows a general homology with the restriction
maps of other class I genes (7, 11, 17, 19, 30). Although there
is a conservation of restriction sites at the 3' end of the
molecule (BamHI, Bgl II), there are considerable differences
in the 5' end. There are no EcoRI, HindIll, or Kpn I sites
within the entire insert, nor are there any 5'-end BamHI sites.









FIG. 2. B10 anti-BlO.F(14R), D-end-specific CTLs recognize
L3a cells. Target cells were from mouse strain BlO.F(14R) (e), B10
(m), or BlO.F(13R) (KPDb) (o) or cell line L3a (A), L12a (A), or LTK+
(0).
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FIG. 3. Restriction map of clone X3a. Restriction sites are as follows: B, BamHI; Bg, BgI II; H, HindIII; P, Pst I; S, Sac I. There are no
EcoRI, Kpn I, Xba I, or HindIII sites within the 3a insert. The coding and intervening sequences were determined by hybridization with cDNAs
as well as homology with mapped and sequenced class I genes.
genome. The restriction endonuclease analyses of Kb, Db,
QJ-QIO, TJ-TS, TJO, and T13 reveal that each has at least one
Kpn I site. In addition, the T6, T7, and T9 genes have HindIII
sites. These restriction sites are also found among the
BALB/c (H-2d) genes (7, 30).
Another interesting feature of the O3a clone is an apparent
700-base-pair (bp) interruption in the 3' end of the coding
sequence. Comparison of the X3a restriction map with that of
Q10 shows conservation of Pst I sites through the exons
encoding the cytoplasmic regions of the polypeptide. The
700-bp Pst I fragment immediately 3' to these sequences does
not hybridize to either of the class I-specific cDNA probes
pH-2IIa and pH-2III. A 2. 1-kilobase (kb) Pst I fragment 3' to
this fragment hybridizes to pH-202 (a full-length cDNA) but
not pH-2IIa. Together, these data suggest interruption of the
3' untranslated region with a 700-bp sequence. We do not
know whether the region is transcribed, but preliminary
experiments using this fragment as a probe suggest this
fragment contains a highly repeated sequence (unpublished
data). It is too long to be the single B2 repeat insertion found
in only D-region class I genes (33). The B2 sequence is found
in the DP gene (unpublished data). We are currently sequenc-
ing this region of O3a and thus far have not found any
homology to B2.
Mapping 3a Sequences by RFLPs. We located the map
position of the O3a gene by use of a RFLP. We can identify,
on a genomic Southern blot of B1O.P DNA, the band that
corresponds to the O3a gene. This is accomplished by
digesting both B1O.P genomic DNA and X3a DNA with Sac
I, which cuts twice within the mouse DNA insert. As in Fig.
4, a 3.0-kb band is seen in the O3a and B1O.P lanes. When
DNA from B10 (H^-2b) is treated identically, although many
bands are present, the 3.0-kb band is absent. A slightly faster






FIG. 4. RFLPs map the X3a clone to the D end of H-2P. Sac
I-digested genomic DNA samples from congeneic and recombinant
mouse strains were analyzed by Southern blot hybridization using
pH-21Ia as probe. Sac I-digested X3a DNA electrophoresed coinci-
dently with Sac I-digested genomic DNAs shows a band at 3.0-kb
(arrow). Lanes: a, B1O.P (KbDb); b, B1O.F(14R) (KbDP); c, B1O.F
(13R) (KPDb); d, B10 (KbDb); e, X3a.
band of much lower intensity can sometimes be seen in blots
of DNA from B10 and BlO.F(13R). The absence of the 3-kb
band signals the change of a Sac I site in or near the B10
equivalent of X3a. Thus, the presence of the 3-kb band can be
used to signal the presence of the X3a p allele. When DNA
from the reciprocal recombinant strains BlO.F(13R) (KPDb)
and B1O.F(14R) (KbDP) is treated similarly, only B1O.F(14R)
DNA shows the 3-kb band. Therefore the X3a gene maps
telomeric to the recombination in B1O.F(14R) in the D or
Tla/Qa regions.
DISCUSSION
We have shown that several class I genes can be expressed
in transfected cells, provoke antibodies reactive with MHC
molecules, and be recognized by allospecific CTLs. We have
not determined the detailed specificity of the antibodies, but
crossreactivity among class I molecules is well documented,
both between K and D, and between Qa-2/TIa-region-
encoded antigens and K. This is expected since the class I
gene family is highly homologous, and many polymorphic
features should be conserved among members of the family.
This is especially likely to be true if gene conversion events
move homologous sequences among the members ofthe class
I family. This type of mechanism is supported by the finding
that the putative donor gene sequence of the KbmI mutation
can be found in a Q-region gene (31, 32).
We have demonstrated that the X3a genomic DNA clone,
which was isolated from an H-2P genomic DNA library,
encodes a novel class I MHC gene. RFLP as well as CTL
analysis indicates that X3a maps in the D-Tla interval. L cells
expressing the X3a gene can both provoke antibody formation
and be recognized by CTLs.
These experiments were directed at uncovering the role of
the previously unsuspected class I sequences identified by
molecular genetic analysis. The structure of the k3a gene is
similar to other previously known class I genes in terms of its
general organization of introns and exons. The restriction
map of X3a differs from other, previously described class I
genes in several ways. It lacks both internal Kpn I and EcoRI
sites. Perhaps more interesting is that the X3a clone has an
apparent insertion of the coding sequence near the 3' end. A
700-bp insertion in the 3' untranslated region was found. The
X3a gene shares many features with other class I genes,
including a BamHI site in intron 3, but shows multiple
differences with all the previously described class I genes.
D-region class I genes share a common insertion of an
-180-bp B2 repetitive element (33). This insert contains both
functional splice acceptor sites and a polyadenylylation
signal. It has been suggested that these may be important in
the independent regulation of D-end genes. The insertion in
X3a is too large to be a single B2 repeat but might also function
in the regulation of X3a.
One explanation for our results would be that the H-2P
haplotype expresses a multiple D-region product (LP, RP,
etc.). Several lines of evidence argue against this. DP, like
other D-region molecules, has a B2 repeat. This repeat is not
present in X3a. Further, no evidence of multiple DP-region
products is suggested by serology. None of the 11 DP-specific
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(data not shown). In contrast, many monoclonal antibodies
crossreact with Ld and Dd. Further, the sequence of DP is
more closely related to Ld and Db than to Dd (unpublished
observation), thus suggesting only a single 0 molecule in
H-2P as in H2b.
The crucial question in understanding class I sequences is
their function. Two major functions have been suggested for
class I determinants. First, it has been shown that they can
function as the targets for H-2-unrestricted cytolytic lym-
phocytes. This means that they are able to be killed by
specific effector cells regardless of shared target/effector cell
expression of K and D antigens. This seems to be a universal
property of class I gene products and is true for the product
expressed by line L3a. Our results, which show that B10
anti-B1O.P cells are able to kill the H-2k JL cells transfected with
the X3a gene but not untransfected LTK- cells, demonstrate
unrestricted killing. The crucial question remains whether this
is a fortuitous event caused by a similarity in structure to
classical antigens. There may be CTL crossreactivity among the
X3a product, KP, DP, and other class I products. It would be
interesting to raise CTL specific for the X3a product by
stimulating CTL cells in vitro. However, we have been unsuc-
cessful in eliciting responses to Ld, DP, or even the endogenous
L-cell H-2k molecules by use of L cells as stimulators.
One intriguing possible explanation for the function of the
class I genes such as that in X3a is that they represent
tissue-specific class I genes. Schultz et al. (34) have found
some evidence for tissue-specific expression of class I genes.
They used grafts of liver to kidneys and showed that the
hierarchy of graft rejection in these liver grafts was different
than for the classically defined skin grafts (34). Thus strain
combinations that showed rapid skin rejection sometimes
showed slow rejection of liver, and vice versa. One expla-
nation for this difference is a differential expression of
different class I genes in skin versus liver. Since these
different class I genes would have different sequences and
hence be recognized as different antigens, it is conceivable
that different rejection rates would be possible.
Many other questions still remain regarding these other
class I sequences. Does the sequence homology correlate
with function? Is there regulation of expression during
development? Are these molecules involved in self-recog-
nition and tolerance? If these genes have no correlation
between structure and function, why are the gene sequences
conserved? Is this conservation selected? Alternatively, is
the class I sequence conservation simply related to the
clustering of class I genes on chromosome 17 and the
influence of the t locus where stability by recombination
suppression is forced? The analysis of the class I gene in L3a
indicates that some of these genes encode functional proteins
that may play important roles in the immune response.
Note Added in Proof. We have found, by hybridization of synthetic
oligonucleotide corresponding to a A3a sequence, that A3a corre-
sponds to either the Q3 or the Q5 gene of BALB/c.
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